Description: Join panelists from three leading pharmaceutical companies for a candid one-hour webinar on multi-support grants. Panelists will also reflect on when sole support is preferred, what factors drive their decision-making, and how CE/CME providers can enhance the likelihood of funding success under each model. Attendees will gain practical insight into how to approach companies, navigate compliance, address potential barriers, and structure collaborations to align with industry priorities. The session will also include dedicated time for live Q&A, giving attendees the opportunity to pose their own questions directly to the panelists.

Panel Speakers:

Annette Schwind, MS, CHCP, FACEHP

Associate Director, Medical Grants & Sponsorships

Takeda

Riaz H. Baxamusa, MBA, FACEhp, CHCP

Associate Director, Independent Medical Education (IME)

Medical Affairs, US

Astellas

Dustin Ensign, CHCP

Director, Medical Education, Research, and External Funding Team Lead

Boehringer Ingelheim Pharmaceuticals

Learning objectives:

• Describe how pharmaceutical companies determine support levels in multi-sponsor CME initiatives when faced with varying budget capacities.

• Identify key compliance considerations when discussing multi-support grants across commercial supporters.

• Recognize actionable strategies CME providers can implement to improve collaboration and success in multi-support CME programs.

• Assess the benefits, challenges, and barriers associated with multi- and sole-support CE funding and align grant requests accordingly